Disclosure 0001193125-26-415531-1

SEC FORM 4

$70,696.65

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 10,340 shares at $6.8372 per share.

Reporting Person Horan Christopher · Officer Title Chief Tech Operations Officer · Transaction Code S

Traded Oct 5, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001193125-26-415531 · filed 2026-10-06 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-10-06. https://desqlong.com/cards/0001193125-26-415531-1 (retrieved 2026-10-07).